monocrotaline has been researched along with Heritable Pulmonary Arterial Hypertension in 94 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 74 (78.72) | 24.3611 |
2020's | 20 (21.28) | 2.80 |
Authors | Studies |
---|---|
Eklund, M; Khoruts, A; Moutsoglou, DM; Prins, KW; Prisco, AR; Prisco, SZ; Thenappan, T; Weir, EK | 1 |
Fu, Q; He, J; Li, M; Peng, J; Tan, S; Tang, M; Tang, Y; Xie, W; Xu, X; Zhang, Q; Zhang, Y; Zheng, Z; Zhu, T | 1 |
Amazit, L; Berrebeh, N; Chaumais, MC; Chelgham, MK; Guignabert, C; Huertas, A; Humbert, M; Le Vely, B; Ottaviani, M; Phan, C; Thuillet, R; Tu, L | 1 |
Carter, LL; Clemons, B; Douthitt, A; Galkin, A; Gandjeva, A; Garcia, E; Guimond, D; Kennedy, M; Osterhout, R; Salter-Cid, L; Sitapara, R; Slee, D; Tuder, RM; Zisman, LS | 1 |
Al-Qazazi, R; Archer, SL; Bentley, RET; Bonnet, S; Chen, KH; Dasgupta, A; Jones, O; Lima, PDA; Martin, AY; Maurice, DH; Mewburn, J; Potus, F; Prins, KW; Prisco, SZ; Provencher, S; Tian, L; Wu, D | 1 |
Aryan, L; Eghbali, M; Li, M; Medzikovic, L; Ruffenach, G | 1 |
Chen, S; Cui, H; Du, GQ; Li, Y; Shen, W; Sun, P; Wang, C; Xue, JY; Zhao, P | 1 |
Cao, M; Li, S; Liu, H; Luan, J; Wang, J; Xue, Y; Zhai, C; Zhang, N; Zhang, Q; Zhu, Y | 1 |
Chen, SA; Chen, YC; Chen, YJ; Higa, S; Kao, YH; Lin, FJ; Lu, YY | 1 |
Lin, S; Ma, H; Ye, P; Yu, WD; Zhang, AK; Zheng, YG | 1 |
Abid, S; Adnot, S; Beaulieu, D; Bernard, D; Born, E; Breau, M; Bulavin, DV; Delcroix, M; Derumeaux, G; Do Cruzeiro, M; Flaman, JM; Gil, J; Houssaini, A; Lefevre, M; Lipskaia, L; Marcos, E; Pierre, R; Quarck, R; Reen, V | 1 |
Liu, Y; Nie, X; Qi, Y; Shang, J; Wu, Z; Zhu, L | 1 |
Chen, YL; Chiang, JY; Guo, J; Huang, CR; Lin, KC; Shao, PL; Sung, PH; Yeh, JN; Yip, HK | 1 |
Ajijola, OA; Banerjee, S; Fishbein, G; Hong, J; Magaki, S; Razee, A; Umar, S | 1 |
Chen, L; Fan, F; Guan, Y; He, H; Liu, M; Qiu, L; Yang, G; Zheng, F | 1 |
Araujo, ASDR; Belló-Klein, A; Campos-Carraro, C; de Lima-Seolin, BG; Teixeira, RB; Turck, P; Zimmer, A | 1 |
Bo, Y; Cui, Z; Tianxin, Y; Weiguo, W; Yi, Y; Zhangchi, L | 1 |
Artigues, E; Cortijo, J; Escrivá, J; Milara, J; Montero, P; Perez-Vizcaino, F; Roger, I | 1 |
Chen, C; Chen, J; Chen, S; Das, A; Fang, Z; Hu, X; Huang, Y; Li, F; Luo, F; Wu, P; Zhou, S | 1 |
Nayeem, MJ; Sato, M; Yamamura, A | 1 |
Choi, SJ; Hong, YM; Kim, KC; Lee, H | 1 |
Didiasova, M; Gungl, A; Klepetko, W; Kosanovic, D; Kwapiszewska, G; Petrovic, A; Schaefer, L; Schermuly, RT; Wujak, L; Wygrecka, M; Zucker, MM | 1 |
Huang, CH; Huang, H; Li, YY; Liu, JC; Liu, ZB; Wu, QC; Xu, H; Xu, QR; Zeng, L; Zhou, XL; Zhu, RR | 1 |
Baal, N; Dorfmuller, P; Ghofrani, HA; Grimminger, F; Jonigk, D; Kojonazarov, B; Neubauer, MC; Neubert, L; Pullamsetti, SS; Ruppert, C; Schermuly, RT; Schlueter, BC; Seeger, W; Weiss, A; Weissmann, N; Yerabolu, D | 1 |
Guo, SS; Han, ZY; He, YY; Jing, ZC; Lin, JH; Pang, XB; Wang, Y; Wang, Z; Xie, XM; Yan, Y; Ye, J; Zhang, JL; Zhao, JH | 1 |
Chowdhury, HM; Li, X; Long, L; Morrell, NW; Nasim, MT; Ogo, T; Schermuly, RT; Torres Cleuren, YN; Trembath, RC; Yang, J | 1 |
Jasińska-Stroschein, M; Orszulak-Michalak, D; Owczarek, J; Łuczak, A | 1 |
Cantoni, S; Galiè, N; Galletti, M; Pasquinelli, G; Ponti, F; Tassinari, R; Valente, S; Ventura, C; Zambelli, F | 1 |
Barrier, M; Biardel, S; Bisserier, M; Bonnet, P; Bonnet, S; Breuils-Bonnet, S; Carter, S; Courchesne, A; Courture, C; Deshaies, Y; Lauzon-Joset, JF; Majka, SM; Meloche, J; Paulin, R; Picard, F; Provencher, S; Racine, C; Tremblay, É | 1 |
Bi, LQ; Kong, H; Kou, JP; Li, N; Wang, H; Wu, SL; Xie, WP; Yu, BY; Zhou, SM; Zhu, R; Zuo, XR | 1 |
Comunoglu, C; Macit, A; Silan, C; Uzun, O; Yavuz, O; Yavuz, T; Yildirim, HA; Yuksel, H | 1 |
Arai, H; Doi, S; Haraguchi, G; Hosokawa, S; Isobe, M; Itai, A; Mizutani, S; Muto, S; Sasaki, A | 1 |
Fan, YF; Jiang, X; Jing, ZC; Liu, D; Wang, YL; Wen, L; Wu, DC; Yuan, P; Zhang, R | 1 |
Li, G; Li, X; Li, Z; Liu, A; Liu, Y; Su, J; Sun, L; Xu, Y; Zhu, Y | 1 |
Bartelds, B; Berger, RM; Borgdorff, MA; de Vroomen, M; Dickinson, MG; Steendijk, P | 1 |
Aguero, J; Benard, L; Dorfmüller, P; Guignabert, C; Hadri, L; Hajjar, RJ; Hulot, JS; Humbert, M; Ibanez, B; Ishikawa, K; Kawase, Y; Kohlbrenner, E; Kratlian, RG; Ladage, D; Leopold, JA; Liang, L; Maron, BA; Turnbull, IC; Zsebo, K | 1 |
Chen, Z; Dixon, RA; Ruan, KH; So, SP; Vanderslice, P; Willerson, JT; Zhou, L | 1 |
Cheng, G; Lu, Y; Luan, Y; Zhang, Z | 1 |
Aliotta, JM; Amaral, A; El-Bizri, R; Hasslinger, A; Igbinoba, Z; Klinger, JR; Pereira, M; Quesenberry, PJ; Rounds, SI; Sorokina, A | 1 |
Guan, RJ; Jiang, H; Wang, HY | 1 |
Bergmeister, H; Bonderman, D; Jakowitsch, J; Lang, IM; Mascherbauer, J; Panzenböck, A; Schreiber, C; Strobl, M; Wexberg, P; Winter, MP | 1 |
Aboagye, EO; Ashek, A; Barnes, G; Cotroneo, E; Cupitt, J; Dabral, S; Dubois, O; El-Bahrawy, MA; Fang, W; Gibbs, JS; Gsell, W; He, JG; Howard, LS; Jones, H; Nguyen, QD; Pullamsetti, SS; Tomasi, G; Wang, L; Wilkins, MR; Zhao, L | 1 |
Chang, HW; Chen, YL; Chua, S; Chung, SY; Hsu, SY; Lee, FY; Leu, S; Lu, HI; Sheu, JJ; Sun, CK; Tsai, TH; Yip, HK; Zhen, YY | 1 |
Martínez, MC | 1 |
Bonnet, S; Breuils-Bonnet, S; Courboulin, A; Couture, C; Graydon, C; Meloche, J; Michelakis, ED; Paulin, R; Pflieger, A; Potus, F; Provencher, S; Tremblay, E; Vaillancourt, M; Zervopoulos, S | 1 |
Bai, Y; Kang, J; Lian, GC; Liu, M; Wang, HL; Wang, HM; Wang, Y; Zhang, XH | 1 |
Chen, YF; Creighton, JR; Fu, J; Guo, Y; Hage, FG; Oparil, S; Xing, DD; Zhao, X | 1 |
Brinckmann, J; Herold, S; Mayer, K; Mižíková, I; Morty, RE; Nave, AH; Niess, G; Reichenberger, F; Seeger, W; Steenbock, H; Talavera, ML; Vadász, I; Veit, F; Weissmann, N | 1 |
Asmis, R; Barabutis, N; Barman, SA; Black, SM; Catravas, JD; Chen, F; Dimitropoulou, C; Fulton, DJ; Giannis, A; Han, W; Jonigk, D; Keri, G; Orfi, L; Rafikov, R; Rafikova, O; Ramesh, G; Stepp, DW; Su, Y; Szabadkai, I; Szantai-Kis, C; Wang, Y | 1 |
Isenberg, JS; Rogers, NM | 1 |
Dai, Z; Guo, Z; Hu, W; Huang, C; Jiang, X; Tang, Y; Wang, X; Yang, B; Yu, S; Zhang, S; Zhao, Q | 1 |
Aliotta, JM; Baird, GL; Del Tatto, M; Dooner, MS; Goldberg, LR; Klinger, JR; Papa, E; Pereira, M; Quesenberry, PJ; Ventetuolo, CE; Wen, S | 1 |
Chen, C; He, JG; Huang, SA; Lei, W; Luo, P; Wu, YC | 1 |
de Boer, MA; Mouchaers, KT; Postmus, PE; Schalij, I; van der Laarse, WJ; van Hinsbergh, VW; van Nieuw Amerongen, GP; Vonk Noordegraaf, A | 1 |
Adcock, IM; Chaumais, MC; Dorfmüller, P; Gambaryan, N; Howard, LS; Humbert, M; Montani, D; Perros, F; Price, LC; Shao, DM; Simonneau, G; Souza, R; Tcherakian, C; Wort, SJ | 1 |
Chen, B; Guo, H; Tang, WL; Wang, X; Yang, J | 1 |
Han, DD; Li, XQ; Wang, HL; Wang, HM; Yang, CG; Zhang, XH | 1 |
Arai, K; Hiramine, K; Ido, A; Kamimura, R; Nuruki, N; Sata, N; Setoyama, K; Tanaka, Y; Tsubouchi, H; Uto, H | 1 |
Chen, L; Li, Y; Ma, H; Xiao, J | 1 |
Jin, H; Mei, Y; Meng, F; Tian, W; Wang, H; Zhang, Z; Zhao, Y | 1 |
Angeli, FS; Bernstein, HS; Boyle, AJ; De Marco, T; Jahn, S; Koskenvuo, JW; Mirsky, R; Ritner, C; Sievers, RE; Yeghiazarians, Y; Yim, SM | 1 |
Chen, XY; Han, B; Hao, W; Jin, YP; Li, YT; Wang, W; Wang, YL | 1 |
Cornitescu, T; Dahal, BK; Ghofrani, HA; Grimminger, F; Hoffmann, J; Kaulen, C; Kosanovic, D; Kuebler, WM; Reiss, I; Savai, R; Schermuly, RT; Seeger, W; Weissmann, N | 1 |
Guan, RJ; Li, XL; Wu, ZY; Xu, QH | 1 |
Delbeck, M; Ellinghaus, P; Kast, R; Laux, V; Nickel, KF; Perzborn, E; Schäfer, S; Schermuly, RT; Strassburger, J; von Degenfeld, G | 1 |
Bache, RJ; Chen, Y; Fassett, J; Geurts, AM; Guo, H; Hu, D; Hu, X; Lu, Z; Ostertag, E; Somani, A; Tang, Q; Weir, EK; Xu, D; Xu, X; Xu, Y | 1 |
Bleackley, RC; Bonnet, S; Dromparis, P; Haromy, A; McMurtry, MS; Michelakis, ED; Sutendra, G | 1 |
Bisserier, M; Bonnet, S; Courboulin, A; Jacob, MH; Meloche, J; Paulin, R | 1 |
das Neves, LA; Gralinski, MR; Huang, J; Nikula, KJ; Senese, PB; Zopf, DA | 1 |
Belló-Klein, A; Berger, B; Leichsenring-Silva, F; Llesuy, S; Mosele, F; Tavares, AM | 1 |
Bartelds, B; Berger, RM; Boersma, B; Borgdorff, MA; Dickinson, MG; Molema, G; Sietsma, H; Takens, J; Weij, M; Wichers, P | 1 |
Dahan, D; Guibert, C; Komohara, Y; Marthan, R; Masuda, H; Morimatsu, Y; Ohnishi, K; Sakashita, N; Takeya, M | 1 |
Hamidi, SA; Jiang, YP; Lin, RZ; Lyubsky, S; Said, SI; Szema, AM | 1 |
Araujo, AS; Belló-Klein, A; Caron-Lienert, R; Colombo, R; Mosele, F; Ribeiro, MF; Tavares, AM | 1 |
Dahal, BK; Ghofrani, HA; Kojonazarov, B; Kwapiszewska, G; Markart, P; Marsh, LM; Meinhardt, A; Olschewski, A; Preissner, KT; Schermuly, RT; Seeger, W; Steinhoff, M; Taube, C; Weissmann, N; Wygrecka, M | 1 |
Hirata, Y; Morita, T; Nagai, R; Sahara, M; Sata, M | 1 |
Archer, SL; Chen, Y; Fang, YH; Hong, Z; Marsboom, G; Morrow, E; Piao, L; Pogoriler, J; Rehman, J; Ryan, JJ; Thenappan, T; Toth, PT; Weir, EK; Wu, X; Zhang, HJ | 1 |
Hu, H; Huang, ZS; Jiang, L; Jiang, YZ; Liu, P; Ouyang, HW; Song, XH; Zeng, CL; Zhu, LJ | 1 |
Guan, RJ; Li, JJ; Li, XL | 1 |
Barreiro, EJ; da Silva, JS; Lima, LM; Nunes, IK; Pontes, LB; Sudo, RT; Zapata-Sudo, G | 1 |
Dong, H; Fernandez, RA; Guo, Q; Makino, A; Pohl, NM; Smith, KA; Yamamura, A; Yamamura, H; Yuan, JX; Zeifman, A; Zimnicka, AM | 1 |
Chaumais, MC; De Man, FS; Dorfmüller, P; Eddahibi, S; Fadel, E; François, C; Girerd, B; Guignabert, C; Huertas, A; Humbert, M; Lecerf, F; Montani, D; Perros, F; Tu, L | 1 |
Anderson, T; Campen, MJ; Candelaria, G; Hesterman, J; Hoppin, J; Irwin, D; Lucas, S; Norenberg, J; Paffett, ML | 1 |
Wang, H; Wang, Q; Wang, YY; Xie, WP; Zhang, M; Zuo, XR | 1 |
Boonstra, A; de Man, FS; Dorfmüller, P; Eddahibi, S; Fadel, E; François, C; Guignabert, C; Handoko, ML; Humbert, M; Perros, F; Postmus, PE; Rain, S; Ruiter, G; Schalij, I; Simonneau, G; Tu, L; van der Velden, J; Vonk-Noordegraaf, A | 1 |
Cui, W; Li, J; Long, C; Wang, H | 1 |
de Man, FS; Handoko, ML; Manders, E; Ottenheijm, CA; Stienen, GJ; van Hees, HW; Vonk-Noordegraaf, A; Westerhof, N | 1 |
Ji, YQ; Liu, CP; Lu, WX; Zeng, Q; Zhang, WH; Zhang, YJ | 1 |
Ceribasi, AO; Demir, T; Kaplan, DS; Kisacik, B; Onat, AM; Orkmez, M; Pehlivan, Y; Sayarlioglu, M; Taysi, S; Turkbeyler, IH; Tutar, E | 1 |
Fang, X; Fung, ML; Huang, Y; Liu, Y; Mao, G; Shyy, JY; Tian, XY; Wang, N | 1 |
Al-Lamki, RS; Berk, J; Li, X; Morrell, NW; Schermuly, RT; Weiss, A; Wu, C; Yang, J | 1 |
Bai, Y; Liu, M; Sun, YX; Wang, HL; Wang, HM; Wang, Y; Zhang, XH | 1 |
Chai, HT; Chang, HW; Chang, LT; Chen, YL; Chua, S; Chung, SY; Ko, SF; Leu, S; Sun, CK; Tsai, CY; Tsai, TH; Yen, CH; Yip, HK | 1 |
Barreiro, EJ; do Nascimento, JH; Ferraz, EB; Fraga, CA; Kummerle, AE; Pereira, SL; Rocha, Nde N; Sudo, RT; Zapata-Sudo, G | 1 |
1 trial(s) available for monocrotaline and Heritable Pulmonary Arterial Hypertension
Article | Year |
---|---|
Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
Topics: Adult; Aged; Animals; Benzamides; Cell Division; Dichloroacetic Acid; Disease Models, Animal; Drug Monitoring; Familial Primary Pulmonary Hypertension; Female; Fibroblasts; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Glycolysis; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Indoles; Lung; Male; Middle Aged; Monocrotaline; Piperazines; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Sunitinib; Young Adult | 2013 |
93 other study(ies) available for monocrotaline and Heritable Pulmonary Arterial Hypertension
Article | Year |
---|---|
Intermittent Fasting Enhances Right Ventricular Function in Preclinical Pulmonary Arterial Hypertension.
Topics: Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Fasting; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Myocytes, Cardiac; Pulmonary Arterial Hypertension; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Right; Ventricular Function, Right | 2021 |
Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
Topics: Animals; Benzhydryl Compounds; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Glucosides; Humans; Hypertension, Pulmonary; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Sildenafil Citrate; Vascular Remodeling | 2022 |
Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Familial Primary Pulmonary Hypertension; Humans; Monocrotaline; Protein-Tyrosine Kinases; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats | 2022 |
Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension.
Topics: Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Hypoxia; Imatinib Mesylate; MicroRNAs; Monocrotaline; Protein Kinase Inhibitors; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats | 2022 |
Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
Topics: Animals; Atrial Natriuretic Factor; Cytokine Receptor gp130; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Fibrosis; Heart Failure; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Inflammasomes; Macrophage Activation; Macrophages; Monocrotaline; NLR Family, Pyrin Domain-Containing 3 Protein; Pulmonary Arterial Hypertension; Rats; Ventricular Dysfunction, Right | 2022 |
HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension.
Topics: Animals; Cell Proliferation; Familial Primary Pulmonary Hypertension; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Hypertension, Pulmonary; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenotype; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; RNA; RNA-Binding Proteins | 2022 |
Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
Topics: Animals; Antioxidants; Arginine Vasopressin; Cysteine; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hepatocyte Growth Factor; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Malondialdehyde; Melatonin; Monocrotaline; NF-E2-Related Factor 2; Proto-Oncogene Proteins; Pulmonary Arterial Hypertension; Rats; RNA, Small Interfering; Ventricular Remodeling | 2022 |
Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation.
Topics: Actins; Animals; Autophagy; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Forkhead Box Protein M1; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Ki-67 Antigen; Monocrotaline; Phosphorylation; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2022 |
Role of Endothelin-1 in Right Atrial Arrhythmogenesis in Rabbits with Monocrotaline-Induced Pulmonary Arterial Hypertension.
Topics: Animals; Arrhythmias, Cardiac; Connexin 43; Disease Models, Animal; Endothelin-1; Familial Primary Pulmonary Hypertension; Monocrotaline; Proto-Oncogene Proteins c-akt; Pulmonary Arterial Hypertension; Pulmonary Artery; Rabbits | 2022 |
Upregulation of miR-335-5p Contributes to Right Ventricular Remodeling via Calumenin in Pulmonary Arterial Hypertension.
Topics: Angiotensin II; Animals; Antagomirs; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypoxia; Mice; MicroRNAs; Monocrotaline; Pulmonary Arterial Hypertension; Rats; Up-Regulation; Ventricular Remodeling | 2022 |
Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
Topics: Animals; Cellular Senescence; Endothelial Cells; Familial Primary Pulmonary Hypertension; Forkhead Transcription Factors; Hypertension, Pulmonary; Hypoxia; Mice; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Senotherapeutics | 2023 |
Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
Topics: Animals; Cell Transdifferentiation; Disease Models, Animal; Endothelial Cells; Familial Primary Pulmonary Hypertension; Glycogen Synthase Kinase 3 beta; Hypertension, Pulmonary; Male; Monocrotaline; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction | 2023 |
Jagged/Notch proteins promote endothelial-mesenchymal transition-mediated pulmonary arterial hypertension via upregulation of the expression of GATAs.
Topics: Animals; Familial Primary Pulmonary Hypertension; Fibronectins; Monocrotaline; Pulmonary Arterial Hypertension; Receptors, Notch; Serrate-Jagged Proteins; Up-Regulation; Vimentin | 2023 |
Thoracic Spinal Cord Neuroinflammation as a Novel Therapeutic Target in Pulmonary Hypertension.
Topics: Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Minocycline; Monocrotaline; Neuroinflammatory Diseases; Pulmonary Arterial Hypertension; Rats; Rats, Sprague-Dawley; Spinal Cord | 2023 |
Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90α axis.
Topics: Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Heat-Shock Proteins; Hypertension, Pulmonary; Hypoxia; Mice; Monocrotaline; Myocytes, Smooth Muscle; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Vascular Remodeling | 2023 |
Copaiba oil improves pulmonary nitric oxide bioavailability in monocrotaline-treated rats.
Topics: Animals; Antioxidants; Biological Availability; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Monocrotaline; Nitric Oxide; Oils, Volatile; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Wistar | 2023 |
Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
Topics: Animals; Atrial Fibrillation; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Fibrosis; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vascular Remodeling | 2023 |
Targeting IL-11 system as a treatment of pulmonary arterial hypertension.
Topics: Animals; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Interleukin-11; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; RNA, Small Interfering | 2023 |
Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China.
Topics: Adult; Animals; Biomarkers; Case-Control Studies; China; Chromatography, High Pressure Liquid; Discriminant Analysis; Familial Primary Pulmonary Hypertension; Fatty Acids; Female; Humans; Lipid Metabolism; Male; Mass Spectrometry; Metabolic Networks and Pathways; Metabolomics; Monocrotaline; Rats; Rats, Sprague-Dawley | 2020 |
The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
Topics: Animals; Cell Line; Cell Proliferation; Familial Primary Pulmonary Hypertension; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Monocrotaline; Muscle, Smooth, Vascular; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats, Sprague-Dawley; rho-Associated Kinases; Up-Regulation; Vascular Remodeling | 2021 |
Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats.
Topics: Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Monocrotaline; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Time Factors | 2017 |
LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
Topics: Actins; Adult; Animals; Antibodies, Neutralizing; Becaplermin; Case-Control Studies; Cell Dedifferentiation; Cell Proliferation; Collagen Type I; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Fibronectins; Gene Expression Regulation; Homeostasis; Humans; Integrin beta1; Low Density Lipoprotein Receptor-Related Protein-1; Male; Mice; Middle Aged; Monocrotaline; Myocytes, Smooth Muscle; Nuclear Proteins; Pulmonary Artery; Rats; Receptors, Platelet-Derived Growth Factor; RNA, Small Interfering; Signal Transduction; Tissue Culture Techniques; Trans-Activators | 2019 |
NSD2 silencing alleviates pulmonary arterial hypertension by inhibiting trehalose metabolism and autophagy.
Topics: Animals; Autophagy; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hemodynamics; Histone-Lysine N-Methyltransferase; Hypertrophy, Right Ventricular; Lung; Male; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats, Sprague-Dawley; Vascular Remodeling | 2019 |
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension.
Topics: Animals; Cell Line; Cyclin-Dependent Kinases; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Indoles; Lung; Male; Mice; Mice, Inbred C57BL; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Piperazines; Protein Kinase Inhibitors; Pulmonary Artery; Pyridines; Pyrroles; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Treatment Outcome | 2019 |
Circulating Plasma Metabolomic Profiles Differentiate Rodent Models of Pulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension Patients.
Topics: Adult; Animals; Biomarkers; Case-Control Studies; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Hypoxia; Male; Metabolomics; Methionine; Monocrotaline; Rats, Sprague-Dawley; Urea | 2019 |
Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension.
Topics: Animals; Bone Morphogenetic Protein Receptors, Type II; Cell Proliferation; Codon, Nonsense; Epoprostenol; Familial Primary Pulmonary Hypertension; HEK293 Cells; Humans; Hypertension, Pulmonary; Lung; Male; MAP Kinase Signaling System; Mice; Monocrotaline; Myocytes, Smooth Muscle; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Smad3 Protein; Transforming Growth Factor beta1 | 2013 |
The beneficial impact of fasudil and sildenafil on monocrotaline-induced pulmonary hypertension in rats: a hemodynamic and biochemical study.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cholesterol, HDL; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; Natriuretic Peptide, Brain; Phosphodiesterase 5 Inhibitors; Piperazines; Protein Kinase Inhibitors; Purines; Rats; Rats, Wistar; rho-Associated Kinases; Sildenafil Citrate; Sulfones; Vascular Endothelial Growth Factor A | 2013 |
Sodium butyrate inhibits platelet-derived growth factor-induced proliferation and migration in pulmonary artery smooth muscle cells through Akt inhibition.
Topics: Acetylation; Animals; Butyric Acid; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Chromones; Familial Primary Pulmonary Hypertension; Gene Expression; Histone Deacetylase Inhibitors; Hypertension, Pulmonary; Male; Monocrotaline; Morpholines; Myocytes, Smooth Muscle; Phosphorylation; Platelet-Derived Growth Factor; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Tissue Culture Techniques | 2013 |
Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Topics: Adult; Aged; Animals; Apoptosis; Arterial Pressure; Bone Morphogenetic Protein Receptors, Type II; Case-Control Studies; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Glycation End Products, Advanced; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indoles; Male; Middle Aged; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; RNA Interference; S100 Proteins; Signal Transduction; STAT3 Transcription Factor; Transfection; Up-Regulation | 2013 |
Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats.
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Arterial Pressure; Caveolin 1; Endothelium, Vascular; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Interleukin-1beta; Male; Monocrotaline; NF-kappa B; Nitric Oxide Synthase Type III; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Spirostans; Thromboplastin | 2013 |
Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension.
Topics: Animals; Antioxidants; Disease Models, Animal; Endothelium, Vascular; Erythrocytes; Familial Primary Pulmonary Hypertension; Hematocrit; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Malondialdehyde; Monocrotaline; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thiocarbamates | 2013 |
Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
Topics: Animals; Antihypertensive Agents; Apoptosis; Benzamides; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Feedback, Physiological; Fibroblast Growth Factor 2; Hypertension, Pulmonary; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Pulmonary Artery; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Time Factors; Tissue Plasminogen Activator; Transcription Factor RelA; Ventricular Function, Right; Ventricular Pressure | 2013 |
The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension.
Topics: Adolescent; Adult; Animals; Case-Control Studies; Cell Proliferation; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Imidazoles; Male; Monocrotaline; Nitric Oxide; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Piperazines; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Sulfones; Triazines; Vardenafil Dihydrochloride; Young Adult | 2013 |
ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Arterial Pressure; Cytoprotection; Disease Models, Animal; Endothelium, Vascular; Enzyme Activation; Enzyme Activators; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Naphthalenes; Neointima; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Resorcinols; Severity of Illness Index; Time Factors; Vasodilation | 2013 |
Distinct loading conditions reveal various patterns of right ventricular adaptation.
Topics: Adaptation, Physiological; Animals; Arteriovenous Shunt, Surgical; Constriction; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Heart Failure; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Models, Cardiovascular; Monocrotaline; Myocardial Contraction; Physical Exertion; Pulmonary Artery; Rats; Rats, Wistar; Stroke Volume; Time Factors; Ultrasonography; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Pressure | 2013 |
Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Down-Regulation; Familial Primary Pulmonary Hypertension; Gene Transfer Techniques; Heart Ventricles; HEK293 Cells; Humans; Hypertension, Pulmonary; Male; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Random Allocation; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Treatment Outcome | 2013 |
Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits.
Topics: Animals; Cyclooxygenase 1; Cytochrome P-450 Enzyme System; Disease Models, Animal; Endothelial Cells; Epoprostenol; Familial Primary Pulmonary Hypertension; Genetic Therapy; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Infusions, Intravenous; Intramolecular Oxidoreductases; Male; Monocrotaline; Rats; Rats, Inbred F344; Stem Cell Transplantation; Survival Rate; Tissue Engineering; Transfection; Treatment Outcome | 2013 |
[Research on effects of bone marrow mononuclear cells implantation on model of experimental pulmonary artery hypertension].
Topics: Animals; Bone Marrow Cells; Cell Transplantation; Dogs; Familial Primary Pulmonary Hypertension; Female; Hypertension, Pulmonary; Leukocytes, Mononuclear; Male; Monocrotaline; Rats | 2013 |
Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice.
Topics: Animals; Apoptosis; Bone Marrow Cells; Bone Marrow Transplantation; Cell Differentiation; Cell Lineage; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Mice; Mice, Inbred C57BL; MicroRNAs; Monocrotaline; Phenotype; RNA, Messenger; Stem Cells; Time Factors; Transport Vesicles | 2013 |
[Fasudil reverses monocrotaline-induced pulmonary hypertension in rats].
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Male; Monocrotaline; Protein Phosphatase 1; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Treatment Outcome | 2013 |
Exhaled nitric oxide measurement to monitor pulmonary hypertension in a pneumonectomy-monocrotaline rat model.
Topics: Animals; Arginine; Arterial Pressure; Biomarkers; Biopterins; Exhalation; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Nitric Oxide; Pneumonectomy; Pulmonary Artery; Random Allocation; Rats; Rats, Sprague-Dawley | 2013 |
Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; bcl-2-Associated X Protein; Caspase 3; Cell Cycle Checkpoints; Cell Line; Colchicine; Connexin 43; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Heart Ventricles; Hypertension, Pulmonary; Lung; Male; Matrix Metalloproteinase 9; Monocrotaline; Myocytes, Smooth Muscle; NF-kappa B; Nicorandil; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Smad3 Protein; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2013 |
Extracellular vesicles: small but strong.
Topics: Animals; Bone Marrow Cells; Endothelial Cells; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Lung; Monocrotaline; Stem Cells; Transport Vesicles | 2013 |
Role for DNA damage signaling in pulmonary arterial hypertension.
Topics: Adult; Aged; Animals; Apoptosis; Benzimidazoles; Cell Proliferation; Cells, Cultured; Disease Models, Animal; DNA Damage; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; Male; MicroRNAs; Middle Aged; Monocrotaline; NFATC Transcription Factors; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Signal Transduction | 2014 |
4-Chloro-DL-phenylalanine protects against monocrotaline‑induced pulmonary vascular remodeling and lung inflammation.
Topics: Animals; Disease Models, Animal; Down-Regulation; Familial Primary Pulmonary Hypertension; Fenclonine; Hypertension, Pulmonary; Intercellular Adhesion Molecule-1; Interleukin-1beta; Lung; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Monocrotaline; Phenylalanine; Pneumonia; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tryptophan Hydroxylase; Tumor Necrosis Factor-alpha | 2014 |
Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.
Topics: Adenoviridae; Animals; Arterial Pressure; Cells, Cultured; Chemokine CCL2; Chemokines, CXC; Disease Models, Animal; Endothelial Cells; Familial Primary Pulmonary Hypertension; Female; Genetic Therapy; Genetic Vectors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Macrophages; Monocrotaline; Neutrophil Infiltration; Neutrophils; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Ovariectomy; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-8; Transduction, Genetic; Up-Regulation; Ventricular Function, Right; Ventricular Remodeling | 2014 |
Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Topics: Adult; Aged, 80 and over; Animals; Antihypertensive Agents; Case-Control Studies; Cell Hypoxia; Cells, Cultured; Collagen; Disease Models, Animal; Elastin; Enzyme Inhibitors; Familial Primary Pulmonary Hypertension; Female; Fibroblasts; Gene Expression Regulation, Enzymologic; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Isoenzymes; Male; Mice; Middle Aged; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protein-Lysine 6-Oxidase; Pulmonary Artery; Rats; RNA, Messenger; Ventricular Dysfunction, Right; Young Adult | 2014 |
NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.
Topics: Adventitia; Animals; Antihypertensive Agents; Cell Movement; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Matrix; Familial Primary Pulmonary Hypertension; Fibroblasts; HEK293 Cells; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indoles; Male; Mice; Mice, Inbred C57BL; Monocrotaline; NADPH Oxidase 4; NADPH Oxidases; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Time Factors; Transfection; Up-Regulation | 2014 |
Endothelial cell global positioning system for pulmonary arterial hypertension: homing in on vascular repair.
Topics: Animals; Endothelial Cells; Familial Primary Pulmonary Hypertension; Female; Genetic Therapy; Hypertension, Pulmonary; Monocrotaline; Pulmonary Artery; Receptors, Interleukin-8 | 2014 |
[Beneficial effects of renal denervation on pulmonary vascular remodeling in experimental pulmonary artery hypertension].
Topics: Angiotensin II; Animals; Blood Pressure; Denervation; Dogs; Echocardiography; Endothelin-1; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Kidney; Lung; Monocrotaline; Pulmonary Artery; Sympathectomy; Vascular Remodeling | 2015 |
Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.
Topics: Animals; Case-Control Studies; Cell-Derived Microparticles; Cells, Cultured; Disease Models, Animal; Exosomes; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice, Inbred C57BL; MicroRNAs; Monocrotaline; Pulmonary Artery; Vascular Remodeling | 2016 |
[Gα11 expression and effect of sildenafil in muscularization of non-muscular pulmonary arterioles in rat with pulmonary arterial hypertension].
Topics: Animals; Arterioles; Familial Primary Pulmonary Hypertension; GTP-Binding Protein alpha Subunits, Gq-G11; Hypertension, Pulmonary; Lung; Monocrotaline; Muscle, Smooth, Vascular; Osteopontin; Piperazines; Random Allocation; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2016 |
Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Familial Primary Pulmonary Hypertension; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Monocrotaline; Piperazines; Pulmonary Artery; Purines; Rats; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilator Agents | 2010 |
Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats.
Topics: Animals; Anti-Inflammatory Agents; Bone Morphogenetic Protein Receptors; Cell Proliferation; Dexamethasone; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Immunohistochemistry; Interleukin-6; Lung; Male; Monocrotaline; Muscle, Smooth; Rats; Rats, Wistar; Treatment Outcome | 2011 |
Suppression of tissue inhibitors of metalloproteinases may reverse severe pulmonary arterial hypertension.
Topics: Animals; Extracellular Matrix; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Matrix Metalloproteinases; Monocrotaline; RNA, Small Interfering; Tissue Inhibitor of Metalloproteinases | 2011 |
Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats.
Topics: Animals; Cytokines; Disease Models, Animal; Extracellular Matrix; Familial Primary Pulmonary Hypertension; Fluoxetine; Hypertension, Pulmonary; Inflammation; Lung; Male; Matrix Metalloproteinase Inhibitors; Monocrotaline; Pulmonary Artery; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Tissue Inhibitor of Metalloproteinases | 2011 |
Hepatocyte growth factor improves the survival of rats with pulmonary arterial hypertension via the amelioration of pulmonary hemodynamics.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; C-Reactive Protein; Constriction, Pathologic; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Hemodynamics; Hepatocyte Growth Factor; Humans; Hypertension, Pulmonary; Male; Monocrotaline; Platelet-Derived Growth Factor; Pulmonary Artery; Rats; Rats, Wistar; Recombinant Proteins; Survival Analysis | 2011 |
Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats.
Topics: Angiotensin I; Animals; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley | 2011 |
Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
Topics: Animals; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; Nitric Oxide; Organ Size; Peptide Fragments; Pulmonary Artery; Rats; Rats, Wistar; Urotensins; Vasodilation | 2011 |
Treatment of pulmonary arterial hypertension with circulating angiogenic cells.
Topics: Animals; Arteries; Cell Movement; Endothelial Cells; Familial Primary Pulmonary Hypertension; Hemodynamics; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Kaplan-Meier Estimate; Monocrotaline; Rats; Rats, Nude; Stem Cell Transplantation; Stem Cells; Ventricular Remodeling | 2011 |
Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension.
Topics: Animals; Blood Pressure; Chemokine CX3CL1; CX3C Chemokine Receptor 1; Dexamethasone; Familial Primary Pulmonary Hypertension; Glucocorticoids; Hypertension, Pulmonary; Interferon-gamma; Interleukin-4; Lung; Male; Monocrotaline; Pulmonary Artery; Random Allocation; Rats; Rats, Wistar; Receptors, Chemokine | 2011 |
Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats.
Topics: Animals; Cell Degranulation; Cromolyn Sodium; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Mast Cells; Monocrotaline; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Ventricular Function, Right; Ventricular Remodeling | 2011 |
[Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
Topics: Animals; Cell Proliferation; Endothelial Cells; Familial Primary Pulmonary Hypertension; Fluorobenzenes; Hypertension, Pulmonary; Hypolipidemic Agents; Male; Monocrotaline; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type III; Proliferating Cell Nuclear Antigen; Pyrimidines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Rosuvastatin Calcium; Sulfonamides | 2011 |
A role for coagulation factor Xa in experimental pulmonary arterial hypertension.
Topics: Animals; Blood Coagulation; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Morpholines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Rivaroxaban; Thiophenes; Thrombosis; Warfarin | 2011 |
Exacerbated pulmonary arterial hypertension and right ventricular hypertrophy in animals with loss of function of extracellular superoxide dismutase.
Topics: Animals; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Male; Mice; Mice, Knockout; Monocrotaline; Mutation; Rats; Superoxide Dismutase | 2011 |
Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension.
Topics: Animals; Etanercept; Familial Primary Pulmonary Hypertension; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypertension, Pulmonary; Immunoglobulin G; Inflammation Mediators; Ion Channel Gating; Ketone Oxidoreductases; Kv1.5 Potassium Channel; Models, Biological; Monocrotaline; Myocytes, Smooth Muscle; Phenotype; Pulmonary Artery; Rats; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2011 |
Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Topics: Adult; Animals; Antihypertensive Agents; Apoptosis; Blotting, Western; Bone Morphogenetic Protein Receptors, Type II; Calcium; Cell Proliferation; Cells, Cultured; Dehydroepiandrosterone; Disease Models, Animal; Enzyme Activation; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; In Situ Nick-End Labeling; Inhibitor of Apoptosis Proteins; Male; Membrane Potential, Mitochondrial; MicroRNAs; Microtubule-Associated Proteins; Middle Aged; Monocrotaline; Muscle, Smooth; Myocytes, Smooth Muscle; NFATC Transcription Factors; Proto-Oncogene Proteins c-pim-1; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Survivin; Vasodilator Agents | 2011 |
C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
Topics: Animals; Arterioles; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Blood Proteins; Familial Primary Pulmonary Hypertension; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy; Male; Monocrotaline; Phenothiazines; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists | 2011 |
Association of the time course of pulmonary arterial hypertension with changes in oxidative stress in the left ventricle.
Topics: Animals; Ascorbic Acid; Cardiomegaly; Familial Primary Pulmonary Hypertension; Glutathione; Heart Ventricles; Hydrogen Peroxide; Hypertension, Pulmonary; Male; Monocrotaline; Oxidative Stress; Rats; Rats, Wistar; Thioredoxin-Disulfide Reductase; Ultrasonography | 2011 |
Egr-1 expression during neointimal development in flow-associated pulmonary hypertension.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Flow Velocity; Early Growth Response Protein 1; Familial Primary Pulmonary Hypertension; Heart Defects, Congenital; Hemodynamics; Humans; Hypertension, Pulmonary; Immunohistochemistry; Monocrotaline; Neointima; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Repressor Proteins | 2011 |
Development and characterization of an animal model of severe pulmonary arterial hypertension.
Topics: Animals; Chronic Disease; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Rats; Rats, Wistar; Tunica Media | 2012 |
VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension.
Topics: Animals; Bosentan; Drug Therapy, Combination; Endothelin Receptor Antagonists; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Monocrotaline; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Sulfonamides; Vasoactive Intestinal Peptide | 2011 |
Effects of purple grape juice in the redox-sensitive modulation of right ventricular remodeling in a pulmonary arterial hypertension model.
Topics: Animals; Beverages; Caspase 3; Disease Models, Animal; Echocardiography; Familial Primary Pulmonary Hypertension; Hydrogen Peroxide; Hypertension, Pulmonary; Lipid Peroxidation; Male; Monocrotaline; Oxidation-Reduction; Rats; Rats, Wistar; Signal Transduction; Thioredoxins; Ventricular Remodeling; Vitis | 2012 |
PAR-2 inhibition reverses experimental pulmonary hypertension.
Topics: Adolescent; Adult; Animals; Antibodies, Neutralizing; Becaplermin; Benzamides; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Imatinib Mesylate; Ligands; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oligopeptides; Piperazines; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, PAR-2; Receptor, Platelet-Derived Growth Factor beta; RNA Interference; Signal Transduction; Time Factors; Transfection; Tryptases; Young Adult | 2012 |
Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
Topics: Animals; Antihypertensive Agents; Apoptosis; Blotting, Western; Caspase 3; Cells, Cultured; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Familial Primary Pulmonary Hypertension; Glyburide; Human Umbilical Vein Endothelial Cells; Humans; Hypertension, Pulmonary; Injections, Intraperitoneal; Male; MAP Kinase Signaling System; Monocrotaline; NG-Nitroarginine Methyl Ester; Nicorandil; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Pressure | 2012 |
Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
Topics: Animals; Antihypertensive Agents; Case-Control Studies; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Proliferation; Cells, Cultured; Cobalt; Cyclin B1; Disease Models, Animal; Dynamins; Enzyme Activation; Familial Primary Pulmonary Hypertension; Genetic Therapy; Glycolysis; GTP Phosphohydrolases; Humans; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Microtubule-Associated Proteins; Mitochondria, Muscle; Mitochondrial Proteins; Mitosis; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Pulmonary Artery; Quinazolinones; Rats; Rats, Sprague-Dawley; RNA Interference; Serine; Time Factors; Transfection | 2012 |
Platelet-mediated mesenchymal stem cells homing to the lung reduces monocrotaline-induced rat pulmonary hypertension.
Topics: Animals; Antibodies; Blood Platelets; Blood Pressure; Bone Marrow Cells; Familial Primary Pulmonary Hypertension; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Lung; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Monocrotaline; P-Selectin; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Sprague-Dawley; Tirofiban; Tyrosine | 2012 |
Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Familial Primary Pulmonary Hypertension; Fluorobenzenes; Gene Expression Regulation, Enzymologic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Nitric Oxide Synthase Type III; Proliferating Cell Nuclear Antigen; Pulmonary Artery; Pyrimidines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; RNA, Messenger; Rosuvastatin Calcium; Sulfonamides; Time Factors | 2012 |
Benzenesulfonamide attenuates monocrotaline-induced pulmonary arterial hypertension in a rat model.
Topics: Animals; Benzenesulfonamides; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Wistar; Sulfonamides; Ventricular Pressure | 2012 |
Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
Topics: Aniline Compounds; Animals; Calcimimetic Agents; Calcium Signaling; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Mice; Mice, Inbred C57BL; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Naphthalenes; Phenethylamines; Propylamines; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; RNA Interference; Spermine; Time Factors; Transfection; Vasoconstriction | 2012 |
A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.
Topics: Animals; Benzamides; Benzimidazoles; Case-Control Studies; Crk-Associated Substrate Protein; Disease Models, Animal; Endothelial Cells; Epidermal Growth Factor; Familial Primary Pulmonary Hypertension; Fibroblast Growth Factor 2; Gefitinib; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Mice; Monocrotaline; Myocytes, Smooth Muscle; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pulmonary Artery; Pyrimidines; Quinazolines; Quinolones; Rats; Signal Transduction | 2012 |
Longitudinal in vivo SPECT/CT imaging reveals morphological changes and cardiopulmonary apoptosis in a rodent model of pulmonary arterial hypertension.
Topics: Animals; Annexins; Apoptosis; Blood Pressure; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Heart Ventricles; Humans; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Myocardium; Perfusion; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Systole; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ventricular Remodeling | 2012 |
Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Disease Models, Animal; Etanercept; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Hypertension, Pulmonary; Immunoglobulin G; Inflammation; Lung; Male; Monocrotaline; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2013 |
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Case-Control Studies; Cells, Cultured; Disease Progression; Endothelium, Vascular; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Losartan; Male; Middle Aged; Monocrotaline; Myocytes, Smooth Muscle; Proportional Hazards Models; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Up-Regulation | 2012 |
Iptakalim ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
Topics: Animals; Endothelin-1; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; KATP Channels; Lung; Male; Monocrotaline; Natriuretic Peptide, Brain; Nitric Oxide; Propylamines; Rats; Rats, Wistar | 2013 |
Diaphragm weakness in pulmonary arterial hypertension: role of sarcomeric dysfunction.
Topics: Animals; Calcium; Diaphragm; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Male; Monocrotaline; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Weakness; Myosin Heavy Chains; Rats; Rats, Wistar; Sarcomeres | 2012 |
Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Arterioles; Carbolines; Disease Models, Animal; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Inflammation Mediators; Interleukin-6; Male; Monocrotaline; Phosphodiesterase 5 Inhibitors; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Simvastatin; Tadalafil; Time Factors; Vasodilator Agents | 2012 |
Urotensin inhibition with palosuran could be a promising alternative in pulmonary arterial hypertension.
Topics: Animals; Arterial Pressure; Arterioles; Endothelin-1; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Pulmonary Artery; Quinolines; Rats; Rats, Wistar; Transforming Growth Factor beta1; Urea; Urotensins | 2013 |
Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
Topics: Animals; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypoxia; Indoles; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Pulmonary Artery; Receptor, Serotonin, 5-HT2B; Rosiglitazone; Serotonin 5-HT2 Receptor Agonists; Thiazolidinediones; Thiophenes; Transcription Factor AP-1; Up-Regulation | 2012 |
Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
Topics: Animals; Antihypertensive Agents; Binding Sites; Bone Morphogenetic Protein 4; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Cell Proliferation; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Disease Models, Animal; Dose-Response Relationship, Drug; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Inhibitor of Differentiation Protein 1; Male; Monocrotaline; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; Phosphodiesterase 5 Inhibitors; Phosphorylation; Piperazines; Promoter Regions, Genetic; Pulmonary Artery; Purines; Rats; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Sildenafil Citrate; Smad1 Protein; Smad5 Protein; Sulfones; Transfection; Vasodilator Agents | 2013 |
Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats.
Topics: Airway Remodeling; Animals; Disease Models, Animal; Down-Regulation; Familial Primary Pulmonary Hypertension; Fluoxetine; Hypertension, Pulmonary; Isoenzymes; Lung; Male; MAP Kinase Signaling System; Monocrotaline; Phosphorylation; Protein Processing, Post-Translational; Protein Transport; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Random Allocation; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Selective Serotonin Reuptake Inhibitors | 2012 |
Sildenafil improves long-term effect of endothelial progenitor cell-based treatment for monocrotaline-induced rat pulmonary arterial hypertension.
Topics: Animals; Cell- and Tissue-Based Therapy; Combined Modality Therapy; Endothelial Cells; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Male; Monocrotaline; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Stem Cell Transplantation; Stem Cells; Sulfones; Time; Vasodilator Agents | 2013 |
A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension.
Topics: Acetylcholine; Animals; Benzodioxoles; Calcium Channel Blockers; Calcium Chloride; Cardiomegaly; Familial Primary Pulmonary Hypertension; Hydrazones; Hypertension, Pulmonary; In Vitro Techniques; Male; Monocrotaline; Phenylephrine; Pulmonary Artery; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilator Agents | 2013 |